APA (7th ed.) Citation

Mathis, T., Baudin, F., Mariet, A., Augustin, S., Bricout, M., Przegralek, L., . . . Hunot, S. (2024). DRD2 activation inhibits choroidal neovascularization in patients with Parkinson’s disease and age-related macular degeneration. Journal of Clinical Investigation, 134(17), 1. https://doi.org/10.1172/JCI174199

Chicago Style (17th ed.) Citation

Mathis, Thibaud, et al. "DRD2 Activation Inhibits Choroidal Neovascularization in Patients with Parkinson’s Disease and Age-related Macular Degeneration." Journal of Clinical Investigation 134, no. 17 (2024): 1. https://doi.org/10.1172/JCI174199.

MLA (9th ed.) Citation

Mathis, Thibaud, et al. "DRD2 Activation Inhibits Choroidal Neovascularization in Patients with Parkinson’s Disease and Age-related Macular Degeneration." Journal of Clinical Investigation, vol. 134, no. 17, 2024, p. 1, https://doi.org/10.1172/JCI174199.